1. Home
  2. EVV vs AVXL Comparison

EVV vs AVXL Comparison

Compare EVV & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVV
  • AVXL
  • Stock Information
  • Founded
  • EVV 2003
  • AVXL 2004
  • Country
  • EVV United States
  • AVXL United States
  • Employees
  • EVV N/A
  • AVXL N/A
  • Industry
  • EVV Finance/Investors Services
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EVV Finance
  • AVXL Health Care
  • Exchange
  • EVV Nasdaq
  • AVXL Nasdaq
  • Market Cap
  • EVV 1.2B
  • AVXL 956.7M
  • IPO Year
  • EVV N/A
  • AVXL N/A
  • Fundamental
  • Price
  • EVV $9.93
  • AVXL $9.34
  • Analyst Decision
  • EVV
  • AVXL Strong Buy
  • Analyst Count
  • EVV 0
  • AVXL 2
  • Target Price
  • EVV N/A
  • AVXL $44.00
  • AVG Volume (30 Days)
  • EVV 323.7K
  • AVXL 1.3M
  • Earning Date
  • EVV 01-01-0001
  • AVXL 08-12-2025
  • Dividend Yield
  • EVV 9.66%
  • AVXL N/A
  • EPS Growth
  • EVV N/A
  • AVXL N/A
  • EPS
  • EVV N/A
  • AVXL N/A
  • Revenue
  • EVV N/A
  • AVXL N/A
  • Revenue This Year
  • EVV N/A
  • AVXL N/A
  • Revenue Next Year
  • EVV N/A
  • AVXL N/A
  • P/E Ratio
  • EVV N/A
  • AVXL N/A
  • Revenue Growth
  • EVV N/A
  • AVXL N/A
  • 52 Week Low
  • EVV $8.52
  • AVXL $5.22
  • 52 Week High
  • EVV $10.07
  • AVXL $14.44
  • Technical
  • Relative Strength Index (RSI)
  • EVV 36.43
  • AVXL 52.33
  • Support Level
  • EVV $9.85
  • AVXL $8.06
  • Resistance Level
  • EVV $10.23
  • AVXL $9.50
  • Average True Range (ATR)
  • EVV 0.10
  • AVXL 0.58
  • MACD
  • EVV -0.02
  • AVXL 0.02
  • Stochastic Oscillator
  • EVV 18.75
  • AVXL 55.19

About EVV Eaton Vance Limited Duration Income Fund of Beneficial Interest

Eaton Vance Ltd Duration Income Fund is a diversified closed-end management investment company. The company's investment objective is to provide a high level of current income. The Fund also seeks capital appreciation. The Fund invests predominantly in Senior Floating-Rate Loans, Debt Obligations, Equity Securities, Derivatives as well as Foreign Securities and Currencies. The Fund invests in various industries, including aerospace and defense, automotive, building and development, healthcare, and leisure, among others.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

Share on Social Networks: